| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |